Icecure Medical Ltd

Research Icecure Medical Ltd (ICCM) on Bullrun: market cap USD 185.22M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 185.22M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 3.38M-USD 15.06M-USD 14.61M36.3%0.24USD 8.90MUSD 13.00KUSD 9.05M
FY2024USD 3.29M-USD 15.32M-USD 12.63M44.1%0.3USD 7.56MUSD 161.00KUSD 6.90M
FY2023USD 3.23M-USD 14.65M-USD 13.03M40.3%0.32USD 10.53MUSD 599.00KUSD 12.16M
FY2022USD 3.09M-USD 16.98M-USD 15.18M46.8%0.46USD 23.66MUSD 737.00KUSD 25.42M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 185.22Mn/an/an/a
20252025-12-31USD 44.60Mn/an/an/a
20242024-12-31USD 63.42Mn/an/an/a
20232023-12-29USD 49.77Mn/an/an/a
20222022-12-30USD 72.07Mn/an/an/a
20212021-12-31USD 111.22Mn/an/an/a

About Icecure Medical Ltd

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Icecure Medical Ltd's market cap?

Icecure Medical Ltd's market capitalization is USD 185.22M.

What does Icecure Medical Ltd do?

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.